Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon

In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the ter...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (198 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548088804498
ctrlnum (CKB)4920000000094853
(oapen)https://directory.doabooks.org/handle/20.500.12854/57762
(EXLCZ)994920000000094853
collection bib_alma
record_format marc
spelling Fabrizio Schifano (Ed.) auth
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
Recent Changes in Drug Abuse Scenario
MDPI - Multidisciplinary Digital Publishing Institute 2019
1 electronic resource (198 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms ‘legal highs’ or ’research chemicals’ have been used to describe these molecules. Overall, about 5% of 19–24-year-old European people have already experimented with them, because both NPS’ intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although ‘novel’ typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon.
English
NPS
drug abuse/misuse
novel psychoactive substances
prescribing drugs’ misuse
3-03897-507-9
language English
format eBook
author Fabrizio Schifano (Ed.)
spellingShingle Fabrizio Schifano (Ed.)
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
author_facet Fabrizio Schifano (Ed.)
author_variant f s e fse
author_sort Fabrizio Schifano (Ed.)
title Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_full Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_fullStr Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_full_unstemmed Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_auth Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_alt Recent Changes in Drug Abuse Scenario
title_new Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
title_sort recent changes in drug abuse scenario: the novel psychoactive substances (nps) phenomenon
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2019
physical 1 electronic resource (198 p.)
isbn 3-03897-508-7
3-03897-507-9
illustrated Not Illustrated
work_keys_str_mv AT fabrizioschifanoed recentchangesindrugabusescenariothenovelpsychoactivesubstancesnpsphenomenon
AT fabrizioschifanoed recentchangesindrugabusescenario
status_str n
ids_txt_mv (CKB)4920000000094853
(oapen)https://directory.doabooks.org/handle/20.500.12854/57762
(EXLCZ)994920000000094853
carrierType_str_mv cr
is_hierarchy_title Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
_version_ 1792839734374957056
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02736nam-a2200325z--4500</leader><controlfield tag="001">993548088804498</controlfield><controlfield tag="005">20231214133307.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03897-508-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094853</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/57762</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094853</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fabrizio Schifano (Ed.)</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Recent Changes in Drug Abuse Scenario</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (198 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms ‘legal highs’ or ’research chemicals’ have been used to describe these molecules. Overall, about 5% of 19–24-year-old European people have already experimented with them, because both NPS’ intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although ‘novel’ typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NPS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug abuse/misuse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel psychoactive substances</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prescribing drugs’ misuse</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03897-507-9</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-07 03:45:16 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338699160004498&amp;Force_direct=true</subfield><subfield code="Z">5338699160004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338699160004498</subfield></datafield></record></collection>